Find Eversense Inserter To Perform Eversense Procedures

Enter your zip code to find the nearest Eversense Inserter trained to perform the insertion and removal procedures for the Eversense 365 and Eversense E3 CGM Systems.

If an Eversense Inserter is not listed near you, it is possible that we haven't received consent for them to be featured on the website. Please contact your Ascensia Diabetes Care Diabetes Therapy Associate (DTA) or Territory Manager to explore additional options for an Eversense Inserter performing sensor insertion and removal in your area.

If you are interested in Eversense, please work with your Eversense Expert before contacting the Eversense Inserter listed below. If you have not connected with an Eversense Expert, please complete the pre-qualification form.

Ascensia provides this service to help people with diabetes find an authorized Eversense Inserter in their area who has experience with Eversense products. Ascensia does not receive payment for this service and does not endorse, recommend, have jurisdiction over, and is not responsible for the actions of any Eversense Inserter.

While we are supplying names of approved Eversense Inserters in your area, we do want you to know that you are responsible for deciding whether you want to have the procedure performed by any of the Eversense Inserters listed. This locator tool is available to you, but the decision to go forward is yours.

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.


Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.